I’d suggest reading the company updates as it’s quite clear how they have been progressing and the milestones they have been hitting each year are towards this. This stock was never for the impatient and you are getting the opportunity still to buy at these levels before ( fingers crossed)FDA approval. These approvals take time and as you will see in their announcements they are working as quickly as they can through that process. Keep in mind they haven’t been talking to the FDA for 6 years and how early they were along this journey at that time too.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-10
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.79 |
Change
-0.045(2.45%) |
Mkt cap ! $153.0M | |||
| Open | High | Low | Value | Volume |
| $1.85 | $1.85 | $1.72 | $127.4K | 72.23K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8620 | $1.74 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.82 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| EMV (ASX) Chart |